BiotechTube
Home/Ridgeline Therapeutics/Suzanne Tomlinson, PhD, MBA
ST

Suzanne Tomlinson, PhD, MBA

Director, Finance & Operations

Ridgeline Therapeutics

Therapeutic Areas

Metabolic DiseasesMusculoskeletal DisordersRenal Disease

Ridgeline Therapeutics Pipeline

DrugIndicationPhase
NNMT Inhibitor ProgramSarcopenia/Frailty, Type 2 Diabetes, Obesity, Muscular Dystrophies, Kidney DiseasePreclinical

Leadership Team at Ridgeline Therapeutics

SW
Stan Watowich, PhD
Founder & CEO
HN
Harshini Neelakantan, PhD
Exec. Director, Research & Development
View full Ridgeline Therapeutics profile